Minneapolis, MN – August 7, 2023 – Berkadia announced today the addition of Director Patrick Abeln to the Medical & Life Sciences platform. Abeln will be based in Minneapolis and will be focusing on debt placement and JV equity structuring. Abeln will report to Senior Managing Director – Head of Medical & Life Sciences Sabrina Solomiany.
“Patrick joining the Medical & Life Sciences platform is pivotal in expanding our mortgage banking capabilities,” said Solomiany. “Patrick has over nine years of experience in the healthcare real estate industry, and I’m thrilled to have him on the team.”
Prior to joining Berkadia, Abeln served as Assistant Vice President at Hammes Partners, an institutional private equity platform that invests exclusively in healthcare real estate. He was responsible for sourcing all financing on acquisition and development projects. He was directly responsible for sourcing over $3 billion in debt from lenders nationwide.
Abeln graduated Magna Cum Laude from Marquette University with a Bachelor of Science in Business Administration degree. He achieved the CFA designation in 2012.
About Berkadia®:
Berkadia, a joint venture of Berkshire Hathaway and Jefferies Financial Group, is a leader in the commercial real estate industry, offering a robust suite of services to our multifamily and commercial property clients. Through our integrated mortgage banking, investment sales and servicing platform, Berkadia delivers comprehensive real estate solutions for the entire life cycle of our clients’ assets.
To learn more about Berkadia, please visit www.berkadia.com.
Media Contacts:
Berkadia Commercial Mortgage LLC
Emily Brebner
PR and Content Marketing Manager
215.328.1862
emily.brebner@berkadia.com
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
